Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin
暂无分享,去创建一个
J. Billard | M. Nosten-Bertrand | B. Giros | F. Tronche | S. Villapol | J. Dupont | M. Holzenberger | Y. Le Bouc | C. Charriaut-Marlangue | Cécile Denis | L. Kappeler | C. D. de Magalhaes Filho | S. Aïd | A. Blaise | Julien Solinc | C. de Magalhaes Filho | C. D. De Magalhaes Filho | Yves Le Bouc | Julien Solinc
[1] A. Messina,et al. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease , 2015, The Journal of Neuroscience.
[2] M. Holzenberger,et al. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance , 2015, The Journal of Neuroscience.
[3] P. Jedlicka,et al. Deletion of the amyloid precursor‐like protein 1 (APLP1) enhances excitatory synaptic transmission, reduces network inhibition but does not impair synaptic plasticity in the mouse dentate gyrus , 2015, The Journal of comparative neurology.
[4] Hugues Berry,et al. Suppression of IGF-I signals in neural stem cells enhances neurogenesis and olfactory function during aging , 2015, Aging cell.
[5] J. Mozrzymas,et al. Impact of matrix metalloproteinase-9 overexpression on synaptic excitatory transmission and its plasticity in rat CA3-CA1 hippocampal pathway. , 2015, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[6] P. Maity,et al. Superoxide anion radicals induce IGF-1 resistance through concomitant activation of PTP1B and PTEN , 2014, EMBO molecular medicine.
[7] Z. Ungvari,et al. Endothelin-1-induced focal cerebral ischemia in the growth hormone/IGF-1 deficient Lewis Dwarf rat. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[8] J. Simpkins,et al. mTOR Signaling Inhibition Modulates Macrophage/Microglia-Mediated Neuroinflammation and Secondary Injury via Regulatory T Cells after Focal Ischemia , 2014, The Journal of Immunology.
[9] F. Metzger,et al. Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1. , 2014, Brain : a journal of neurology.
[10] I. Torres-Aleman,et al. Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury , 2014, F1000Research.
[11] J. Dupont,et al. Longevity effect of IGF-1R+/− mutation depends on genetic background-specific receptor activation , 2013, Aging cell.
[12] Wenhua Zheng,et al. Glutamate attenuates IGF-1 receptor tyrosine phosphorylation in mouse brain: Possible significance in ischemic brain damage , 2012, Neuroscience Research.
[13] E. Benarroch. Insulin-like growth factors in the brain and their potential clinical implications , 2012, Neurology.
[14] J. Schneider,et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.
[15] D. Munoz,et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. , 2012, The Journal of clinical investigation.
[16] I. Torres-Aleman,et al. The many faces of insulin-like peptide signalling in the brain , 2012, Nature Reviews Neuroscience.
[17] R. Kulkarni,et al. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion. , 2011, Gastroenterology.
[18] C. Bass,et al. Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression , 2011, Neuroscience.
[19] P. Ye,et al. Blunting type 1 insulin-like growth factor receptor expression exacerbates neuronal apoptosis following hypoxic/ischemic injury , 2011, BMC Neuroscience.
[20] Federica Madia,et al. Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans , 2011, Science Translational Medicine.
[21] Sarah A. Stern,et al. A critical role for IGF-II in memory consolidation and enhancement , 2011, Nature.
[22] Angel Nuñez,et al. Neuronal Activity Drives Localized Blood-Brain-Barrier Transport of Serum Insulin-like Growth Factor-I into the CNS , 2010, Neuron.
[23] Ehud Cohen,et al. Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection , 2010, Aging cell.
[24] Rosemary O’Connor,et al. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling , 2010, Neurobiology of Aging.
[25] Pablo Blinder,et al. Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice , 2009, Cell.
[26] A. Aleman,et al. Circulating insulin-like growth factor I and cognitive function: Neuromodulation throughout the lifespan , 2009, Progress in Neurobiology.
[27] T. Kadowaki,et al. Neuronal IGF‐1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] W. Young,et al. Postischemic IGF-1 Gene Transfer Promotes Neurovascular Regeneration after Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] F. Tronche,et al. IGF-1R contributes to stress-induced hepatocellular damage in experimental cholestasis. , 2009, The American journal of pathology.
[30] Sang-H Choi,et al. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. , 2009, Trends in pharmacological sciences.
[31] M. Blüher,et al. Autocrine IGF-1 Action in Adipocytes Controls Systemic IGF-1 Concentrations and Growth , 2008, Diabetes.
[32] M. Endres,et al. Serum insulin-like growth factor I and ischemic brain injury , 2007, Brain Research.
[33] I. Torres-Aleman,et al. Targeting insulin-like growth factor-1 to treat Alzheimer's disease , 2007, Expert opinion on therapeutic targets.
[34] Mary F. Lopez,et al. IGF2 knockout mice are resistant to kainic acid-induced seizures and neurodegeneration , 2007, Brain Research.
[35] A. Shuaib,et al. Critical role of microvasculature basal lamina in ischemic brain injury , 2007, Progress in Neurobiology.
[36] I. Torres-Aleman,et al. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects , 2007, Molecular Psychiatry.
[37] I. Torres-Aleman,et al. Calcineurin in Reactive Astrocytes Plays a Key Role in the Interplay between Proinflammatory and Anti-Inflammatory Signals , 2007, The Journal of Neuroscience.
[38] B. Bu,et al. Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo , 2007, Glia.
[39] Bruno Giros,et al. Parallel Loss of Hippocampal LTD and Cognitive Flexibility in a Genetic Model of Hyperdopaminergia , 2007, Neuropsychopharmacology.
[40] F. Tronche,et al. Hepatocyte proliferation during liver regeneration is impaired in mice with liver‐specific IGF‐1R knockout , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[41] P. Gluckman,et al. The insulin-like growth factor system and its pleiotropic functions in brain. , 2005, Endocrine reviews.
[42] M. Holzenberger,et al. Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury , 2005, Respiratory research.
[43] I. Torres-Aleman,et al. Insulin-like growth factor I is required for vessel remodeling in the adult brain. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[44] David R. Kaplan,et al. ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3 , 2004, The Journal of cell biology.
[45] R. Swanson,et al. Astrocyte influences on ischemic neuronal death. , 2004, Current molecular medicine.
[46] J. Dupont,et al. Biology of insulin-like growth factors in development. , 2003, Birth defects research. Part C, Embryo today : reviews.
[47] I. Torres-Aleman,et al. Glutamate excitotoxicity attenuates insulin-like growth factor-i prosurvival signaling , 2003, Molecular and Cellular Neuroscience.
[48] A. Gunn,et al. Insulin-like growth factor-1 and post-ischemic brain injury , 2003, Progress in Neurobiology.
[49] I. Robinson,et al. Growth hormone-releasing hormone (GHRH) neurons in GHRH-enhanced green fluorescent protein transgenic mice: a ventral hypothalamic network. , 2003, Endocrinology.
[50] I. Torres-Aleman,et al. Brain repair and neuroprotection by serum insulin-like growth factor I , 2003, Molecular Neurobiology.
[51] Martin Holzenberger,et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.
[52] J. Argente,et al. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. , 2002, Endocrinology.
[53] S. Vannucci,et al. IGF‐I and microglia/macrophage proliferation in the ischemic mouse brain , 2002, Glia.
[54] S. Vannucci,et al. Experimental Stroke in the Female Diabetic, db/db, Mouse , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[55] S. Orkin,et al. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Staiger,et al. Efferent projections from the lateral septal nucleus to the anterior hypothalamus in the rat: A study combining Phaseolus vulgaris-leucoagglutinin tracing with vasopressin immunocytochemistry , 1990, Cell and Tissue Research.
[57] I. Torres-Aleman,et al. Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury. , 2014, F1000Research.
[58] M. Block,et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.
[59] S. Vannucci,et al. Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice. , 2004, The Journal of clinical investigation.
[60] Wolfgang Schmid,et al. Disruption of CREB function in brain leads to neurodegeneration , 2002, Nature Genetics.
[61] S. Levine,et al. Anoxic-ischemic encephalopathy in rats. , 1960, The American journal of pathology.